Interferon in the management of chronic hepatitis B (original) (raw)
References
Centers for Disease Control: Hepatitis Surveillance. Report number 53, December, 1990
CDC: Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 39:1–26, 1990 Google Scholar
Szmuness W, Harley EJ, Ikram H, Stevens CE: Sociodemographic aspects of the epidemiology of hepatitis B.In Viral Hepatitis. Etiology, Epidemiology, Pathogenesis and Prevention. GN Vyas, SN Cohen, R Schmid (eds). Philadelphia, Franklin Institute Press, 1978, pp 297–320 Google Scholar
Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR: Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 108:616–625, 1988 Google Scholar
Beasley RP: Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology 2:215–265, 1982 Google Scholar
Feinman SV, Berris B, Cootner N, Sinclair JC, Wrobel DM: Results of a long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state. Hepato-Gastroenterol 29:58–61, 1982 Google Scholar
Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J: The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 277:17–22, 1979 Google Scholar
Dudley FJ, Scheuer PJ, Sherlock S: Natural history of hepatitis associated antigen-positive chronic liver disease. Lancet 2:1388–1393, 1972 Google Scholar
Weissberg JI, Andres LL, Smith CL, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB: Survival in chronic hepatitis. An analysis of 379 patients. Ann Intern Med 101:613–616, 1984 Google Scholar
Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal, in the treatment of chronic hepatitis B. N Engl J Med 323:295–301, 1990 Google Scholar
Liaw YF, Tai D-I, Chuc C-M, Chen T-J: The development of cirrhosis in patients with chronic type hepatitis: A prospective study. Hepatology 8:493–496, 1988 Google Scholar
Beasley RP, Hwang LY: Epidemiology of hepatocellular carcinoma.In Viral Hepatitis and Liver Disease. GN Vyas, JL Dienstag, JH Hoofnagle (eds). New York, Grune & Stratton, 1984, pp 209–224 Google Scholar
McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP: Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 150:1051–1054, 1990 Google Scholar
Hall AJ, Alveyn CG, Winter PD, Wright R: Mortality of hepatitis B-positive blood donors in England and Wales.In Viral Hepatitis and Liver Disease. AJ Zuckerman (ed). New York, Alan R. Liss, 1988, pp 192–194 Google Scholar
Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl T: Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13:619–626, 1991 Google Scholar
O'Grady JG, Williams R: Liver transplantation for viral hepatitis. Br Med Bull 46:481–491, 1990 Google Scholar
Szmuness W, Prince AM, Hirsch RL, Brotman B: Familial clustering of hepatitis B infections. N Engl J Med 289:1162–1166, 1973 Google Scholar
Perrillo RP, Gelb L, Campbell C, Wellinghoff W, Ellis FR, Overby L, Aach RD: Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus. Gastroenterology 76:1319–1325, 1979 Google Scholar
Bernier RH, Sampliner R, Gerety R, Tabor E, Hamilton F, Nathanson N: Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen. Factors associated with prevalence of infection. Am J Epidemiol 116:199–211, 1982 Google Scholar
Margolis HS, Alter MJ, Hadler SC: Hepatitis B: Evolving epidemiology and implications for control. Semin Liv Dis 11:84–92, 1991 Google Scholar
Hoofnagle JH, Seeff LB: Natural history of chronic type B hepatitis. Prog Liver Dis 7:469–479, 1982 Google Scholar
Di Bisceglie AM: Hepatocellular carcinoma. Ann Intern Med 108:390–401, 1988 Google Scholar
Fattovich G, Brollo L, Alberti A, Giustina G, Pontisso P, Realdi G, Ruol A: Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. J Hepatol 11:29–33, 1990 Google Scholar
Chadwick RG, Galizzi J, Heathcote J, Lyssiotis T, Cohen BJ, Scheuer PJ, Sherlock S: Chronic persistent hepatitis: Hepatitis B virus markers and histological follow up. Gut 20:372–377, 1979 Google Scholar
Hoofnagle JH, Shafritz DA, Popper H: Chronic type B hepatitis and the “healthy” HBsAg carrier state. Hepatology 7:758–763, 1987 Google Scholar
Perrillo RP, Campbell CR, Sanders GE, Regenstein FG, Bodicky CJ: Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. Ann Intern Med 100:43–46, 1984 Google Scholar
Davis GL, Hoofnagle JH, Waggoner JG: Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86:230–235, 1984 Google Scholar
A Trial Group of the European Association for the Study of the Liver: Steroids in chronic B hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long term treatment on survival. Liver 6:227–232, 1986 Google Scholar
Realdi G, Alberti A, Rugge M, Bortolotti F, Rigoli AM, Tremolada F, Ruol A: Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 79:195–199, 1980 Google Scholar
Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH: Immunology and the liver. Hepatology 13:977–994, 1991 Google Scholar
Abb J, Zachoval R, Eisenburg J, Pape GR, Zachoval V, Deinhardt F: Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J Med Virol 16:171–176, 1985 Google Scholar
Jicha DL, Davis GL, Peters MG, Hoofnagle JH, Jones EA: Effects of recombinant human leukocyte interferon treatment on endogeneous interfeon production in patients with chronic type B hepatitis. J Interferon Res 6:13–20, 1986 Google Scholar
Ikeda T, Pignatelli M, Lever AML, Thomas HC: Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection. Gut 27:1498–1501, 1986 Google Scholar
Mondelli MG, Mieli-Vergani G, Alberti A, Vergani B, Portmann B, Eddleston ALWF, Williams R: Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: Evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129:2773–2781, 1982 Google Scholar
Montano L, Miescher GC, Goodhall AH, Wiedmann KH, Janossy G, Thomas HC: Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology 2:557–561, 1982 Google Scholar
Eddleston ALWF: Immunological aspects of hepatitis B infection.In Viral Hepatitis and Liver Disease. AJ Zuckerman (ed). New York: Alan R. Liss, 1988, pp 603–605 Google Scholar
Pasquinelli C, Laure F, Chatenoud L, Beaurin G, Gazengal C, Bismuth H, Degos F, Tiollais P, Bach JF, Brechot C: Hepatitis B virus DNA in mononuclear blood cells. J Hepatol 3:95–103, 1986 Google Scholar
Peters M, Davis GL, Dooley JS, Hoofnagle JH: The interferon system in acute and chronic viral hepatitis. Prog Liver Dis 89:453–468, 1986 Google Scholar
Kirchner H: Interferons, a group of multiple lymphokines. Springer Semin Immunopathol 7:347–374, 1984 Google Scholar
Peters M: Mechanisms of action of interferons. Semin Liver Dis 9:235–239, 1989 Google Scholar
Armstrong RW, Gurwith MJ, Waddell D, Merigan TC: Cutaneous interferon production in patients with Hodgkin's disease and other cancers interferon with Varicella or Vaccinia. N Engl J Med 283:1182–1187, 1970 Google Scholar
Stewart WE: The Interferon System, 2nd ed. New York, Springer-Verlag, 1979 Google Scholar
Gresser I, Tovey MG, Bandu M-T, Maury C, Brouty-Boye D: Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med 144:1305–1315, 1976 Google Scholar
Gresser I, Tovey MG, Maury C, Bandu M-T: Role of inteferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Maloney sarcoma, vesiculostomatitis, Newcastle disease and influenza viruses. J Exp Med 144:1316–1323, 1976 Google Scholar
Samuel CE: The interferon-induced protein P1/eIF-2 alpha kinase.In The Interferon System: A Current Review to 1987. S Baron, GJ Stanton, WR Fleischmann (eds). Austin, University of Texas Press, 1987, pp 373–381 Google Scholar
Peters M: Immunological aspects of antiviral therapy. Springer Semin Immunopathol 12:47–56, 1990 Google Scholar
Pignatelli M, Waters J, Brown D, Lever A, Iwarson S, Schaff Z, Gerety R, Thomas HC: HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology 6:349–353, 1986 Google Scholar
Chu CM, Shyu WC, Kuo RY, Liaw YF: HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis. Hepatology 6:1311–1316, 1987 Google Scholar
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506–512, 1987 Google Scholar
Chen L, Mathieu-Mahul D, Bach FH, Dausset J, Bensussan A, Sasportes M: Recombinant interferon alpha can induce rearrangement of T cell antigen receptor alpha genes and maturation in cytotoxicity in T lymphocyte clones_in vitro_. Proc Natl Acad Sci USA 83:4887–4889, 1986 Google Scholar
Daniels HM, Meager A, Eddleston ALWF, Alexander GJM, Williams R: Spontaneous production of tumor necrosis factor alpha and interleukin-1 beta during interferon alpha treatment of chronic HBV infection. Lancet 335:875–877, 1990 Google Scholar
Billiau A: The mode of action of interferons in viral infections and their possible role in the control of hepatitis B. J Hepatol 3(suppl 2):S171-S179, 1986 Google Scholar
Castilla A, Prieto J, Fausto N: Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 324:933–940, 1991 Google Scholar
Brook MG, McNamara AL, Perrillo RP, Cabal CM, Campbell CR: Quantitation of hepatitis B viral DNA by solution hybridization: Comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J Med Virol 27:274–281, 1989 Google Scholar
Brook MG, Petrovic L, McDonald JA, Scheuer PJ, Thomas HC: Histological improvement after anti-viral treatment for chronic hepatitis B virus infection. J Hepatol 8:218–225, 1989 Google Scholar
Di Bisceglie AM, Waggoner JG, Hoofnagle JH: Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after viral therapy. Gastroenterology 93:1236–1241, 1987 Google Scholar
Lok ASF, Ma OCK, Lau JYN: Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver. Gastroenterology 100:756–761, 1991 Google Scholar
Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC: Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue tissue specimens. N Engl J Med 305:1067–1073, 1981 Google Scholar
Caselmann WH, Eisenburg J, Hofschneider PH, Koshy R: Beta and gamma interferon chronic active hepatitis B. A pilot trial of short-term combination therapy. Gastroenterology 96:449–455, 1981 Google Scholar
Scullard GH, Pollard RB, Smith JL, Sacks GL, Gregory PB, Robinson WS, Merigan TC: Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis 143:772–783, 1981 Google Scholar
Brook MG, Karayiannis P, Thomas HC: Which patients with chronic hepatitis B virus infection will respond to alpha interferon therapy? A statistical analysis of predictive factors. Hepatology 10:761–763, 1989 Google Scholar
Lok ASF, Lai CL, Wu PC, Lau JYN, Leung EKY, Wong LSK, Fung YL: Alpha interferon treatment in Chinese patients with chronic hepatitis B. J Hepatol 11:S121-S125, 1990 Google Scholar
Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Ann Intern Med 109:95–100, 1988 Google Scholar
Novick DM, Lok ASF, Thomas HC: Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. J Hepatol 1:29–35, 1984 Google Scholar
McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JRW, Forster GE, Thomas HC: Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha interferon. Hepatology 7:719–723, 1987 Google Scholar
Roonbloom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115:178–183, 1991 Google Scholar
Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65:2237–2242, 1990 Google Scholar
Greenberg HBV, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC: Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 295:517–522, 1976 Google Scholar
Perrillo RP: Treatment of chronic hepatitis B with interferon: Experience in Western countries. Semin Liver Dis 9:240–248, 1989 Google Scholar
Katkov WN, Dienstag JL: Prevention and therapy of viral hepatitis. Semin Liver Dis 11:165–174, 1991 Google Scholar
Seeff LB, Koff RS: Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis 6:11–22, 1986 Google Scholar
Davis GFL, Hoofnagle JH: Interferon in viral hepatitis: Role in pathogenesis and treatment. Hepatology 6:1038–1041, 1986 Google Scholar
Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Hallahan C, Park Y, Meschievitz C, Jones EA: Randomized, controlled trial of recombinant human alpha interferon patients with chronic hepatitis B. Gastroenterology 95:1318–1325, 1988 Google Scholar
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981 Google Scholar
Fevery J, Elewaut A, Michielsen P, Nevens F, Van Eyken P, Adler M, Desmet V: Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. J Hepatol 11:S108-S112, 1990 Google Scholar
Perez V, Tanno H, Villamil F, Fay O: Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis. J Hepatol 11:S121-S125, 1990 Google Scholar
Muller R, Baumgarten R, Markus R, Schulz M, Wittenberg H, Hintsche-Kilger B, Fengler JD, Von Wussow P, Meisel H, Klein H, Malmus K, Schmidt FW: Treatment of chronic hepatitis B with interferon alfa-2b. J Hepatol 11:S137-S140, 1990 Google Scholar
Waked I, Amin M, El Fattah SA, Osman LM, Sabbour MS: Experience with interferon in chronic hepatitis B in Egypt. J Chemother 2:310–318, 1990 Google Scholar
Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, Ma OCK, Lauder IJ, Ng CPL, Chung HT: A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 102:2091–2097, 1992 Google Scholar
Di Bisceglie AM, Bergasa NV, Fong TL, Fried MW, Swain M, Baker B, Korenman J, Waggoner JG, Park Y, Hoofnagle JH: Randomized, controlled trial of recombinant alpha interferon therapy for chronic hepatitis B. Hepatology 13:70A, 1991 (abstract) Google Scholar
Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, Aguado JG, Carreno V: Prospective, randomized controlled trial of interferon alpha in children with chronic hepatitis B. Hepatology 13:1035–1039, 1991 Google Scholar
Scullard GH, Smith CU, Merigan TC, Robinson WS, Gregory PB: Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 81:987–991, 1981 Google Scholar
Rakela J, Redeker AG, Weliky B: Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 84:956–960, 1983 Google Scholar
Perrillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC: Comparative efficacy of adenine arabinoside 5′-monophosphate and prednisone withdrawal followed by adenine arabinoside 5′-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 88:780–786, 1985 Google Scholar
Yokosuka O, Omata M, Imazeki F, Hirota K, Mora J, Uchiumi K, Ito Y, Okuda K: Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. Gastroenterology 89:246–251, 1985 Google Scholar
Omata M, Imazeki F, Yokosuka O, Ito Y, Uchiumi K, Mori J, Okuda K: Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance and biologic effects. Gastroenterology 88:870–880, 1985 Google Scholar
Sagnelli E, Maio G, Felaco GM, Izzo CM, Manzillo G, Pasquale G, Filippini P, Piccinino F: Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis. Lancet 2:395–397, 1980 Google Scholar
Perrillo RP, Regenstein FG: Corticosteroid therapy for chronic active hepatitis B: Is a little too much? Hepatology 6:1416–1418, 1986 (editorial) Google Scholar
Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C: Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver 5:8–12, 1985 Google Scholar
Hess GH, Manns M, Hutteroth TH, Meyer zum Buschenfelde KH: Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: Effect on viral replication and liver cell damage. Digestion 36:47–54, 1987 Google Scholar
Renault PF, Hoofnagle JH: Side effects of alpha interferon. Semin Liver Dis 9:273–277, 1989 Google Scholar
Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Brian-Jones D, Rustgi V, Jones EA: Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 147:1577–1580, 1987 Google Scholar
McDonald EM, Mann AH, Thomas HC: Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant gamma interferon in hepatitis B carriers. Lancet 2:1175–1177, 1987 Google Scholar
Perrillo RP: Treatment of chronic hepatitis B.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore, William and Wilkins, 1991, pp 616–623 Google Scholar
Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Buschenfelde KH: Treatment of chronic type B hepatitis with recombinant alpha interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10:24–28, 1989 Google Scholar
Burman P, Karlsson FA, Oberg K: Autoimmune thyroid disease in interferon treated patients. Lancet 2:100–101, 1985 Google Scholar
Craxi A, Di Marco V, Volpes R, Palazzao U: Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis. Hepato-Gastroenterol 35:304–305, 1988 Google Scholar
Porres JC, Carreno V, Ruiz M, Marron JA, Bartolome J: Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon. J Hepatol 8:351–357, 1989 Google Scholar
Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag J, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 321:1501–1506, 1989 Google Scholar
Lok ASF, Lai CL, Leung EKY: Interferon antibodies may negate the antiviral effects of recombinant alpha interferon treatment in patients with chronic hepatitis B virus infection. Hepatology 12:1266–1270, 1990 Google Scholar
Williams SJ, Farrell GC: Inhibition of antipyrine metabolism by interferon. Br J Clin Pharmacol 22:610–612, 1986 Google Scholar
Williams SJ, Baird-Lambert JA, Farrell CGC: Inhibition of theophylline metabolism by interferon. Lancet 2:939–941, 1987 Google Scholar
Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH: Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 114:629–634, 1991 Google Scholar
Perrillo RP, Brunt EM: Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen. Ann Intern Med 115:113–115, 1991 Google Scholar
Karayiannis P, Kanatakis S, Thomas HC: Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment. J Hepatol 10:350–352, 1990 Google Scholar
Chung HT, Lok ASF, Lin HJ, Lai CL: Hepatitis B virus DNA using polymerase chain reaction in sera of chronic hepatitis B patients treated with alpha interferon.In Proceedings of the 1990 International Symposium on Viral hepatitis and Liver Disease, p 129 (abstract)
Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R: Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 103:1649–1656, 1992 Google Scholar
Fong T-L, Di Bisceglie AM, Feinstone SM, Waggoner JG, Axiotis CA, Hoofnagle JH: Persistent hepatitic HBV-DNA after clearance of HBsAg from serum of patients with chronic Hepatitis B. Hepatology 14:130A, 1991 (abstract) Google Scholar
Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, Verme G, Bonino F: Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 10:198–202, 1989 Google Scholar
Rosina F, Garripoli A, Lattore V, Fabiano A, Rizzetto M: Medical management of chronic delta hepatitis.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore, Williams & Wilkins, 1991, pp 627–629 Google Scholar
Garcia G, Scullard G, Smith C, Weissberg J, Alexander S, Robinson WS, Gregory P, Merigan TC: Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatology 5:317–320, 1985 Google Scholar
Mizushima N, Kanai K, Matsuda H, Matsumoto M, Tamakoshi K, Ishii H, Nakajima T, Yoshimi T, Kimura M, Nagase M: Improvement of proteinuria in a case of hepatitis B associated glomerulonephritis after treatment with interferon. Gastroenterology 92:524–526, 1987 Google Scholar
Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park Y, Hoofnagle JH: Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Intern Med 3:479–483, 1989 Google Scholar
Kassianides C, Di Bisceglie AM, Hoofnagle JH, Mullen K, Peters M, Rustgi V, Jones B, Lisker-Melman M, Park Y, Waggoner JG, Jones EA: Alpha interferon therapy in patients with decompensated chronic type B hepatitis.In Viral Hepatitis and Liver Disease. AJ Zuckerman (ed). New York, Alan R. Liss, 1988, pp 840–843 Google Scholar
Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y: Alpha interferon treatment of patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology (in press)
Perrillo R, Tamburro C, Regenstein F, Balart L, Bodenheimer H, Schiff E, Silva M, Albrecht J, Bodicky C, Campbell C, Miller B, Taylor B, Brodeur C, Roach K: Treatment of decompensated chronic hepatitis B (CHB) with a titrable, low dose regimen of recombinant interferon alfa-2b. Hepatology 16:126A, 1992 Google Scholar